Rochelle Wynne

Rochelle Wynne

Auto-generated profile, based on publicly available information

Rochelle Wynne

Deakin University

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in JACC
Verified
Journal Article
Closed access
EBEdward Buratto
Edward Buratto
WSWilliam Y. Shi
William Y. Shi
RWRochelle Wynne
Rochelle Wynne
CPChin L. Poh
Chin L. Poh
MLMarco Larobina
Marco Larobina
PSPeter D. Skillington
Peter D. Skillington

31 July 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ABAnna Boltong
Anna Boltong
SASanchia Aranda
Sanchia Aranda
RKRussell Keast
Russell Keast
RWRochelle Wynne
Rochelle Wynne
PFPrudence A Francis
Prudence A Francis
KGKarla Gough
Karla Gough
‘Taste’ changes are commonly reported during chemotherapy. It is unclear to what extent this relates to actual changes in taste function or to changes in appetite and food liking and how these changes affect dietary intake and nutritional status. This prospective, repeated measures cohort study recruited participants from three oncology clinics. Women (n = 52) prescribed adjuvant chemotherapy underwent standardised testing of taste perception, appetite and food liking at six time points to measure change from baseline. Associations between taste and hedonic changes and nutritional outcomes were examined. Taste function was significantly reduced early in chemotherapy cycles (p<0.05) but showed recovery by late in the cycle. Ability to correctly identify salty, sour and umami tastants was reduced. Liking of sweet food decreased early and mid-cycle (p<0.01) but not late cycle. Liking of savory food was not significantly affected. Appetite decreased early in the cycle (p<0.001). Reduced taste function was associated with lowest kilojoule intake (r = 0.31; p = 0.008) as was appetite loss with reduced kilojoule (r = 0.34; p = 0.002) and protein intake (r = 0.36; p = 0.001) early in the third chemotherapy cycle. Decreased appetite early in the third and final chemotherapy cycles was associated with a decline in BMI (p = <0.0005) over the study period. Resolution of taste function, food liking and appetite was observed 8 weeks after chemotherapy completion. There was no association between taste change and dry mouth, oral mucositis or nausea. The results reveal, for the first time, the cyclical yet transient effects of adjuvant chemotherapy on taste function and the link between taste and hedonic changes, dietary intake and nutritional outcomes. The results should be used to inform reliable pre-chemotherapy education.

1 July 2009 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
JTJames Tatoulis
James Tatoulis
BBBrian F. Buxton
Brian F. Buxton
JFJohn A. Fuller
John A. Fuller
MMManish Meswani
Manish Meswani
STSanjay Theodore
Sanjay Theodore
RWRochelle Wynne
Rochelle Wynne

1 February 2015 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PSPeter D. Skillington
Peter D. Skillington
MMM. Mostafa Mokhles
M. Mostafa Mokhles
JTJohanna Takkenberg
Johanna Takkenberg
MLMarco Larobina
Marco Larobina
MOMichael O'KEefe
Michael O'KEefe
JTJames Tatoulis
James Tatoulis

1 April 2013 in Journal of Thoracic Oncology
Verified
Journal Article
Closed access
PDF file
PRPrudence A. Russell
Prudence A. Russell
SBStephen A. Barnett
Stephen A. Barnett
MWMarzena Walkiewicz
Marzena Walkiewicz
ZWZoe Wainer
Zoe Wainer
MCMatthew Conron
Matthew Conron
TJThomas John
Thomas John

1 January 2004 in Chest
Verified
Journal Article
Closed access
PDF file
RWRochelle Wynne
Rochelle Wynne
MBMari Botti
Mari Botti
HSHilary Stedman
Hilary Stedman
LHLynda Holsworth
Lynda Holsworth
MHMaria Harinos
Maria Harinos
CMChristianne Manterfield
Christianne Manterfield